Article
14 Aug 2025
Health Care Marketing Enforcement: FTC Targets Telehealth Company For Deceptive Weight Loss Marketing Claims
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
13 Aug 2025
FDA Calls For Stronger Industry Collaboration On Infant And Child Food Recalls
Article
11 Aug 2025
GLP-1 Drugs: Ohio Board Of Pharmacy Issues FAQs For Compounders
Article
29 Jul 2025
GLP-1 Receptor Agonists: Clinical Trial Considerations
Article
18 Jul 2025
Gender-Affirming Care: Key Takeaways From FTC's July 2025 Workshop On Unfair Or Deceptive Trade Practices
Article
17 Jul 2025
FDA: Commissioner's National Priority Voucher Program Aims To Streamline Some Drug Reviews
Article
25 Jun 2025
Direct-To-Consumer Drug Ads Are Under Attack – Pharmaceutical Companies Beware
Article
09 Jun 2025
GLP-1 Compounded Medications Targeted By Connecticut Attorney General
Article
20 May 2025
"AI Policy Roadmap" Released By AdvaMed To Guide Regulators
Article
19 May 2025
Drug Pricing: Trump Signs "Most Favored Nation" Executive Order
Article
16 May 2025
Data Transactions: DOJ's Final Rule's Implications For Academic Medical Centers With Clinical Research Programs
Article
25 Apr 2025
Health Care Marketing: The Seventh Circuit Addresses "Referrals" Under The Anti-Kickback Statute
Article
24 Apr 2025
MedTech Round Table: What The Trump Administration Means For Companies And Investors
Article
24 Apr 2025
Prescription Drugs: Executive Order Aims To Lower Prices
Article
05 Apr 2025
Texas Court Vacates FDA's Laboratory Developed Test (LDT) Final Rule
Article
19 Mar 2025
Compounded GLP-1 Drugs: Texas Judge Denies PI Motion And Request For Stay Of FDA's Declaration That Tirzepatide Shortage Is Resolved; Plaintiff OFA Appeals
Article
07 Feb 2025
FDA & OHRP Draft Guidance: Including Tissue Biopsies In Clinical Trials
Article
10 Jan 2025
Scientific Information On Unapproved Uses Of Medical Products: FDA's Final Guidance On Firm Communication To Health Care Providers
Article
09 Jan 2025
AI-Enabled Device Software Functions: FDA's Final Guidance For Predetermined Change Control Plans
Article
02 Jan 2025
GLP-1 Drugs: FDA "Re-Confirms" Decision Removing Tirzepatide From The Drug Shortage List